Counsyl DNA Service Expands Into Oncology to Advance Cancer Genetic Screening

Counsyl DNA Service Expands Into Oncology to Advance Cancer Genetic Screening
Counsyl, a DNA testing and genetic counseling service committed to help patients understand how their DNA can inform critical health decisions, has announced it will expand into the oncology market. It plans to focus on advancing risk screening and help cancer prevention efforts with potential implications in breast cancer, which has a strong genetic component. The announcement was made last month before Counsyl’s exhibition at the American Society of Clinical Oncology (ASCO) Annual Meeting June 3-7 in Chicago. According to a news release, the company’s launch into the oncology market includes:
  • An oncology-focused business unit, created with a dedicated sales force that will work with oncologists to help patients and their families understand their real risk of several inherited forms of cancer so they can make proactive decisions about preventive care and treatment;
  • The enhancement of Counsyl’s Inherited Cancer Screen – The company expanded the test for up to 36 genes associated with an increased risk of more than 10 different cancer types, including breast, ovarian, pancreatic, colon, prostate, and melanoma. Tests include on-demand genetic counseling and are connected with most insurance providers so that patients can access them through their in-office physician. Results are typically available within two weeks;
  • The pilot software tool "FirstCare" – a web and mobile-friendly app that will help physicians easily determine a patient’
    Subscribe or to access all post and page content.